Notice of Concern (NOC) for Panexcell Clinical Lab Pvt Ltd published
M
Sandoz’ rituximab prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First clofazimine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First ivermectin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Guilin’s DHA/piperaquine 60/480 mg tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
CALL FOR NOMINATIONS: Roster of Experts for Assessment of Covid-19 Vaccines
V
CLOSING DATE: 30 September 2020
WHO will commence the screening of submissions and assessment of Covid-19 vaccine candidates.
Newly prequalified Quality Control Laboratories (QCLs)
M
New addition to the List of Prequalified Quality Control